<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Geedkar D</submitter><pubmed_abstract>The present work elicits a novel approach to combating COVID-19 by synthesizing a series of azo-anchored 3,4-dihydroimidazo[4,5-b]indole derivatives. The envisaged methodology involves the L-proline-catalyzed condensation of para-amino-functionalized azo benzene, indoline-2,3-dione, and ammonium acetate precursors with pertinent aryl aldehyde derivatives under ultrasonic conditions. The structures of synthesized compounds were corroborated through FT-IR, &lt;sup>1&lt;/sup>H NMR, &lt;sup>13&lt;/sup>C NMR, and mass analysis data. Molecular docking studies assessed the inhibitory potential of these compounds against the main protease (M&lt;sup>pro&lt;/sup>) of SARS-CoV-2. Remarkably, in silico investigations revealed significant inhibitory action surpassing standard drugs such as Remdesivir, Paxlovid, Molnupir</pubmed_abstract><journal>Scientific reports</journal><pagination>10419</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11074333</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (M&lt;sup>pro&lt;/sup>).</pubmed_title><pmcid>PMC11074333</pmcid><pubmed_authors>Sharma P</pubmed_authors><pubmed_authors>Kumar A</pubmed_authors><pubmed_authors>Geedkar D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (M&lt;sup>pro&lt;/sup>).</name><description>The present work elicits a novel approach to combating COVID-19 by synthesizing a series of azo-anchored 3,4-dihydroimidazo[4,5-b]indole derivatives. The envisaged methodology involves the L-proline-catalyzed condensation of para-amino-functionalized azo benzene, indoline-2,3-dione, and ammonium acetate precursors with pertinent aryl aldehyde derivatives under ultrasonic conditions. The structures of synthesized compounds were corroborated through FT-IR, &lt;sup>1&lt;/sup>H NMR, &lt;sup>13&lt;/sup>C NMR, and mass analysis data. Molecular docking studies assessed the inhibitory potential of these compounds against the main protease (M&lt;sup>pro&lt;/sup>) of SARS-CoV-2. Remarkably, in silico investigations revealed significant inhibitory action surpassing standard drugs such as Remdesivir, Paxlovid, Molnupir</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-01T08:04:18.415Z</modification><creation>2026-04-08T10:48:52.82Z</creation></dates><accession>S-EPMC11074333</accession><cross_references><pubmed>38710746</pubmed><doi>10.1038/s41598-024-57795-4</doi></cross_references></HashMap>